Abstract
Titanium alloys are extensively utilised in orthopaedic and dental implants; however, concerns related to corrosion-induced ion release and implant-associated infections necessitate advanced surface engineering strategies. In this investigation, micro-arc oxidation (MAO) was employed to fabricate bioactive oxide coatings on Ti6Al7Nb alloy, followed by addition of silver nanoparticles (AgNPs) to impart antibacterial functionality. The performance of MAO-coated Ti6Al7Nb was systematically compared with Ti6Al4V ELI under identical processing conditions. Surface characterization revealed a porous TiO2-based coating composed of anatase and rutile phases with uniformly incorporated Ca and P. Electrochemical impedance spectroscopy demonstrated a bilayer coating structure, having porous outside layer and a dense inside barrier layer responsible for superior corrosion resistance. The inner layer resistance of Ti–6Al–7Nb (97,980 Ω.cm2) exceeded that of Ti–6Al–4V ELI, indicating enhanced electrochemical stability, likely associated with the presence of niobium oxide. Biocompatibility assessment using MTT assay showed that MAO-coated Ti–6Al–7Nb achieved the highest average cell viability (94.53%), significantly exceeding the ISO 10993-5 threshold of 70% and outperforming uncoated counterparts. Incorporation of AgNPs resulted in stronger antibacterial performance verses S. aureus and E. coli, having a maximum inhibition zone of 16.5 millimetre at 1.5 g/L silver nanoparticles concentration. The antibacterial effect was concentration-dependent and attributed to membrane disruption and sustained Ag+ ion release. Overall, the combined improvements in corrosion resistance, cytocompatibility, and antibacterial performance demonstrate that AgNP-incorporated MAO-coated Ti6Al7Nb is a highly promising candidate for next-generation implants requiring long-term stability and infection resistance.
Get full access to this article
View all access options for this article.
